Antiresorptive treatment of postmenopausal osteoporosis: review of randomized clinical studies and rationale for the Evista alendronate comparison (EVA) trial.

Source:http://linkedlifedata.com/resource/pubmed/id/15025844

Download in:

View as

General Info

PMID
15025844